JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3)

Clinical trials for JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3) explained in plain language.

Never miss a new study

Get alerted when new JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3) trials appear

Sign up with your email to follow new studies for JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists gather clues in fight against rare, fatal childhood brain disease

Knowledge-focused Recruiting now

This study aims to collect information and biological samples from people with Batten disease (CLN3) and their family members. The goal is to identify measurable signs, or 'markers,' of the disease that can be used to test future treatments in clinical trials. Researchers will fo…

Matched conditions: JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3)

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) • Aim: Knowledge-focused

Last updated Mar 30, 2026 14:32 UTC

JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3)

Get alerted when new JUVENILE NEURONAL CEROID LIPOFUSCINOSIS (CLN3) trials appear

Scientists gather clues in fight against rare, fatal childhood brain disease